Oncolytic viruses for therapy of malignant glioma

   
Sosnovtceva A.O.1 , Grinenko N.F.2, Lipatova A.V.3, Chumakov P.M.3, Chekhonin V.P.4

1. Pirogov Russian National Research Medical University, Moscow, Russia
2. Serbsky Federal Medical Research Center for Narcology and Psychiatry, Moscow, Russia
3. Engelhardt institute of molecular biology RAS, Moscow, Russia
4. Pirogov Russian National Research Medical University, Moscow, Russia; Serbsky Federal Medical Research Center for Narcology and Psychiatry, Moscow, Russia
Section: Review
DOI: 10.18097/PBMC20166204376      PubMed Id: 27562991
Year: 2016  Volume: 62  Issue: 4  Pages: 376-390
Effective treatment of malignant brain tumors is still an open problem. Location of tumor in vital areas of the brain significantly limits capasities of surgical treatment. The presence of tumor stem cells resistant to radiation and anticancer drugs in brain tumor complicates use of chemoradiotherapy and causes a high rate of disease recurrence. A technological improvement in bioselection and production of recombinant resulted in creation of viruses with potent oncolytic properties against glial tumors. Recent studies, including clinical trials, showed, that majority of oncolytic viruses are safe. Despite the impressive results of the viral therapy in some patients, the treatment of other patients is not effective; therefore, further improvement of the methods of oncolytic virotherapy is necessary. High genetic heterogeneity of glial tumor cells even within a single tumor determines differences in individual sensitivity of tumor cells to oncolytic viruses. This review analyses the most successful oncolytic virus strains, including those which had reached clinical trials, and discusses the prospects for new approaches to virotherapy of gliomas.
Download PDF:  
Keywords: oncolytic virus, malignant glioma, virotherapy, antitumor therapy
Citation:

Sosnovtceva, A. O., Grinenko, N. F., Lipatova, A. V., Chumakov, P. M., Chekhonin, V. P. (2016). Oncolytic viruses for therapy of malignant glioma. Biomeditsinskaya Khimiya, 62(4), 376-390.
References  
 2024 (vol 70)
 2023 (vol 69)
 2022 (vol 68)
 2021 (vol 67)
 2020 (vol 66)
 2019 (vol 65)
 2018 (vol 64)
 2017 (vol 63)
 2016 (vol 62)
 2015 (vol 61)
 2014 (vol 60)
 2013 (vol 59)
 2012 (vol 58)
 2011 (vol 57)
 2010 (vol 56)
 2009 (vol 55)
 2008 (vol 54)
 2007 (vol 53)
 2006 (vol 52)
 2005 (vol 51)
 2004 (vol 50)
 2003 (vol 49)